RANDOMIZED CONTROLLED CLINICAL TRIAL OF ERAND TAILA YONIPICHU IN THE MANAGEMENT OF PARIPLUTA YONIVYAPAD WITH SPECIAL REFERENCE TO CHRONIC PELVIC INFLAMMATORY DISEASE.
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishoola,Ruja
Study Overview
Brief Summary
Paripluta yonivyapad has been chosen for the present study which is seen in married women of reproductive age (21-50yrs). Need has always been felt to develop certain ayurvedic treatment modalities for the management of Paripluta Yonivyapad (Chronic Pelvic inflammatory Disease) which could be safe, effective, readily available, cost effective, without any side effects in comparison to the therapeutic procedures of different systems of medicine. Ayurveda has holistic approach towards the treatment of Paripluta Yonivyapad with their backgrounds an effort is made to evaluate the efficacy of Erand taila yoni pichu in series of patients suffering from Paripluta Yonivyapad (Chronic Pelvic inflammatory Disease). The Erand taila is having properties as vata kapha shamak,Madhur vipak,kashay rasa because of these properties it help to overcome the symptoms of Paripluta Yonivyapad by increasing local immunity and prevent recurrence of symptoms in patients
Study Design
- Study Type
- Interventional
- Allocation
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 21.00 Year(s) to 50.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •1.Only Married women in between Age group of 21-50 yrs.
- •Patient having specific symptoms of chronic pelvic inflammatory disease like chronic pain in abdomen, previous history of acute pelvic inflammatory disease malaise associated with lower abdominal pain and tenderness.
Exclusion Criteria
- •1.Patients having Malignant or Benign tumor, Polyp, Fibroid, Endometriosis, Tubo-Ovarian Mass, Adenomyosis etc.
- •Pregnant women 3.Unmarried women 4.Known case of Diabetes mellitus,HTN ,Asthma
- •Patients with pelvic inflammatory disease when seen associated with prolapsed uterus.
- •6 Known case of HIV ,VDRL.
Outcomes
Primary Outcomes
Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishoola,Ruja
Time Frame: 7 Days
Secondary Outcomes
- Significant Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishool,Ruja(2 Month)
Investigators
DrPallavi Dinkar Kamthe
LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur